Safe and effective barrier against contamination during TSCPC

Article

Using a sterile, disposable barrier for the G-probe transsceleral cyclophotocoagulation (TSCPC) device is a safe and effective method of preventing contamination in consecutive patients.

Using a sterile, disposable barrier for the G-probe transsceleral cyclophotocoagulation (TSCPC) device is a safe and effective method of preventing contamination in consecutive patients, according to a study published in the Journal of Glaucoma.

An investigation led by Dr Daniel B. Rootman, University of Toronto, Canada, measured diode laser output with and without the G-probe barrier both pre- and post- TSCPC. After each test, the barrier was inspected for microperforations and debris. Microbiology was recorded on the cadaver eye and after 20 cycles of the G-probe.

It was found that there was a statistically significant difference between the diode laser output with and without the G-probe barrier both pre- and post- TSCPC and the laser focus dispersion was reduced by the G-probe cover.

However, when using the G-probe barrier the clinicians found no evident perforations or any debris on the G-probe post-treatment.

Therefore, it was concluded that use of the barrier was effective when trying to avoid contamination during TSCPC.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Andreas Pollreisz, MD, discusses widefield OCT-A and fluorescence angiography at the 2025 European Society of Retina Specialists EURETINA meeting
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
© 2025 MJH Life Sciences

All rights reserved.